S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
ASX:MYX

Mayne Pharma Group Limited (MYX.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.43
MA: A$0.43
A$0.43
52-Week Range N/A
Volume5.47 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Korea, and internationally. The company operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. It also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

MarketRank

Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-8-82092666
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$456.98 million
Book ValueA$0.62 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive MYX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mayne Pharma Group Limited (MYX.AX) (ASX:MYX) Frequently Asked Questions

What stocks does MarketBeat like better than Mayne Pharma Group Limited (MYX.AX)?

Wall Street analysts have given Mayne Pharma Group Limited (MYX.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mayne Pharma Group Limited (MYX.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Mayne Pharma Group Limited (MYX.AX)'s next earnings date?

Mayne Pharma Group Limited (MYX.AX) is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Mayne Pharma Group Limited (MYX.AX)
.

How were Mayne Pharma Group Limited (MYX.AX)'s earnings last quarter?

Mayne Pharma Group Limited (MYX.AX) (ASX:MYX) posted its quarterly earnings data on Friday, February, 22nd. The company reported $0.02 earnings per share for the quarter.
View Mayne Pharma Group Limited (MYX.AX)'s earnings history
.

Who are some of Mayne Pharma Group Limited (MYX.AX)'s key competitors?

What other stocks do shareholders of Mayne Pharma Group Limited (MYX.AX) own?

Who are Mayne Pharma Group Limited (MYX.AX)'s key executives?

Mayne Pharma Group Limited (MYX.AX)'s management team includes the following people:
  • Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 56, Pay $1.47M)
  • Mr. Peter Paltoglou, Chief Financial Officer
  • Mr. Stefan J. Cross, Pres of International Operations (Age 47)
  • Ms. Lisa Pendlebury, VP of Investor Relations & Communications
  • Ms. Kate Rintoul, Exec. VP & Gen. Counsel
  • Dr. Andrew O. Herdman Ph.D., VP of Group HR
  • Mr. Brant Schofield, Exec. VP of Specialty Brands Division (Age 54)
  • Mr. Daniel Moore, Exec. VP of Generics Products Division
  • Mr. Brenton Walter, Financial Controller
  • Mr. John S. Ross, Pres of Mayne Pharma USA

What is Mayne Pharma Group Limited (MYX.AX)'s stock symbol?

Mayne Pharma Group Limited (MYX.AX) trades on the ASX under the ticker symbol "MYX."

How big of a company is Mayne Pharma Group Limited (MYX.AX)?

Mayne Pharma Group Limited (MYX.AX) has a market capitalization of $0.00 and generates $456.98 million in revenue each year. Mayne Pharma Group Limited (MYX.AX) employs 780 workers across the globe.

What is Mayne Pharma Group Limited (MYX.AX)'s official website?

The official website for Mayne Pharma Group Limited (MYX.AX) is www.maynepharma.com.

How can I contact Mayne Pharma Group Limited (MYX.AX)?

Mayne Pharma Group Limited (MYX.AX)'s mailing address is 1538 Main North Rd, ADELAIDE, SA 5106, Australia. The company can be reached via phone at +61-8-82092666.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.